BENEVENTO, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 1.380
EU - Europa 724
AS - Asia 428
AF - Africa 72
SA - Sud America 5
Totale 2.609
Nazione #
US - Stati Uniti d'America 1.376
GB - Regno Unito 154
IT - Italia 147
CN - Cina 131
SG - Singapore 128
SE - Svezia 122
DE - Germania 109
VN - Vietnam 101
IE - Irlanda 45
IN - India 43
TG - Togo 42
RU - Federazione Russa 27
CH - Svizzera 22
FR - Francia 20
BG - Bulgaria 16
FI - Finlandia 12
ZA - Sudafrica 12
EE - Estonia 11
JO - Giordania 11
BE - Belgio 8
HR - Croazia 8
NG - Nigeria 8
UA - Ucraina 8
CI - Costa d'Avorio 7
MK - Macedonia 6
ID - Indonesia 5
CL - Cile 4
CA - Canada 3
UZ - Uzbekistan 3
ES - Italia 2
NL - Olanda 2
AR - Argentina 1
AT - Austria 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
IR - Iran 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MU - Mauritius 1
MX - Messico 1
SA - Arabia Saudita 1
SC - Seychelles 1
TW - Taiwan 1
Totale 2.609
Città #
Fairfield 173
Chandler 168
Ashburn 142
Southend 142
Singapore 111
Dong Ket 100
Woodbridge 88
Seattle 74
Santa Clara 66
Houston 60
Wilmington 56
Boardman 49
Bologna 46
Dublin 45
Princeton 43
Lomé 42
Cambridge 41
Ann Arbor 39
Bern 21
New York 19
Sofia 16
Redmond 14
Westminster 14
Beijing 13
Turin 13
Nanjing 12
Washington 12
Amman 11
Berlin 10
Shenyang 10
Helsinki 9
Abeokuta 8
Bremen 8
Brussels 8
Abidjan 7
Milan 7
Padova 7
Saint Petersburg 7
Des Moines 6
Florence 6
Fort Worth 6
Jinan 6
Skopje 6
Jakarta 5
Los Angeles 5
San Diego 5
Guangzhou 4
Mountain View 4
Redwood City 4
Taiyuan 4
Wuhan 4
Zhengzhou 4
Borgo Tossignano 3
Falkenstein 3
Frankfurt am Main 3
Fremont 3
Haikou 3
Lappeenranta 3
London 3
Medford 3
Nanchang 3
Napoli 3
Norwalk 3
Rome 3
Shanghai 3
Ancona 2
Bühl 2
Chengdu 2
Dearborn 2
Esslingen am Neckar 2
Ferrara 2
Hangzhou 2
Hebei 2
Hounslow 2
Kuban 2
Leawood 2
Lucca 2
Lübeck 2
Mirano 2
Monmouth Junction 2
Moscow 2
Ningbo 2
Olalla 2
Ottawa 2
Paris 2
Shenzhen 2
Shijiazhuang 2
Acton 1
Alfonsine 1
Amsterdam 1
Anyang 1
Augusta 1
Bari 1
Bellinzago Novarese 1
Cairo 1
Castelnuovo Rangone 1
Chisinau 1
Chongqing 1
Correggio 1
Costa Mesa 1
Totale 1.876
Nome #
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. 189
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 159
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 149
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 135
An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib 123
Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib 121
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 119
null 117
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives 113
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure 108
Anticoagulation in Cirrhotic Portal Vein Thrombosis: No Harm, but Survival Benefit Still Unclear 108
Pattern of macrovascular invasion in hepatocellular carcinoma 108
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 95
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: Correlation with MGMT promoter methylation status 90
Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019 87
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 81
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3) 78
null 77
SAT-453-Effects of sorafenib on pancreatic volume and their clinical implications in patients with hepatocellular carcinoma 74
Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma 69
Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery 67
Experience with regorafenib in the treatment of hepatocellular carcinoma 67
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 63
null 56
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 51
Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma 40
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 35
Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients 35
An update on atezolizumab for hepatocellular carcinoma 33
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 30
Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC 25
Totale 2.702
Categoria #
all - tutte 8.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.827


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020284 0 0 0 0 0 40 53 64 66 36 12 13
2020/2021387 40 21 4 6 50 40 15 25 44 19 20 103
2021/2022507 52 7 15 21 46 32 9 33 19 31 178 64
2022/2023625 46 90 30 82 47 49 36 36 117 14 35 43
2023/2024291 16 50 29 18 41 64 10 19 21 11 5 7
2024/2025372 41 76 71 63 91 30 0 0 0 0 0 0
Totale 2.702